129 reports of this reaction
1.6% of all POLYVINYL ALCOHOL, POVIDONE reports
#18 most reported adverse reaction
PHOTOPHOBIA is the #18 most commonly reported adverse reaction for POLYVINYL ALCOHOL, POVIDONE, manufactured by Geri-Care Pharmaceuticals, Corp. There are 129 FDA adverse event reports linking POLYVINYL ALCOHOL, POVIDONE to PHOTOPHOBIA. This represents approximately 1.6% of all 8,211 adverse event reports for this drug.
Patients taking POLYVINYL ALCOHOL, POVIDONE who experience photophobia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PHOTOPHOBIA is a less commonly reported adverse event for POLYVINYL ALCOHOL, POVIDONE, but still significant enough to appear in the safety profile.
In addition to photophobia, the following adverse reactions have been reported for POLYVINYL ALCOHOL, POVIDONE:
The following drugs have also been linked to photophobia in FDA adverse event reports:
PHOTOPHOBIA has been reported as an adverse event in 129 FDA reports for POLYVINYL ALCOHOL, POVIDONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PHOTOPHOBIA accounts for approximately 1.6% of all adverse event reports for POLYVINYL ALCOHOL, POVIDONE, making it a notable side effect.
If you experience photophobia while taking POLYVINYL ALCOHOL, POVIDONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.